Lessee, Operating Lease, Liability, to be Paid, Year Four of Chemomab Therapeutics Ltd. from 31 Dec 2019 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary: Chemomab Therapeutics Ltd. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four in USD history and change rate from 31 Dec 2019 to 31 Dec 2024.
Chemomab Therapeutics Ltd. Lessee, Operating Lease, Liability, to be Paid, Year Four for the quarter ending 31 Dec 2024 was $106,000, a 12% decline year-over-year.
Source SEC data: View on sec.gov

Lessee, Operating Lease, Liability, to be Paid, Year Four, Quarterly (USD)

Lessee, Operating Lease, Liability, to be Paid, Year Four, YoY Quarterly Change (%)

Chemomab Therapeutics Ltd. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Four (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$106,000	-$15,000	-12%	31 Dec 2024	20-F	04 Apr 2025	2024	FY
Q4 2023	$121,000			31 Dec 2023	20-F	28 Mar 2024	2023	FY
Q4 2021	$117,000			31 Dec 2021	10-K	30 Mar 2022	2021	FY
Q4 2019	$57,000			31 Dec 2019	10-K	17 Mar 2020	2019	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.